SCHEMBL29351914

SCHEMBL29351914

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ ENPEP Q07075 14/20 0.48
▸ SLC7A5 Q01650 1/20 0.47
▸ CTSD P07339 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14941289 0.97 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL9491298 0.97 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL9491302 0.97 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL16698375 0.97 ALDH1A1 (0.53) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL29453382 0.94 CTSD (0.48) ALDH1A1ENPEPSLC7A5CTSD
SCHEMBL30051564 0.94 ALDH1A1 (0.47) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL29351403 0.93 SLC7A5 (0.43) ALDH1A1ENPEPSLC7A5CTSD
SCHEMBL29350950 0.93 ALDH1A1 (0.46) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL30052478 0.91 ALDH1A1 (0.47) ALDH1A1ENPEPSLC7A5CTSDL3MBTL1
SCHEMBL30051651 0.91 MME (0.50) ALDH1A1ENPEPSLC7A5CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240270793-A1 COMPOSITIONS UNIVERSITY OF SOUTHAMPTON (GB) 2024-08-15 — — US claimed
EP-4247838-A1 COMPOSITIONS UNIVERSITY OF SOUTHAMPTON (GB) 2023-09-27 — — EP claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 — — CN claimed
CN-113880912-B Short peptide and application thereof in epilepsy treatment 中国医科大学 2023-06-23 — — CN claimed
WO-2022106825-A1 COMPOSITIONS UNIVERSITY OF SOUTHAMPTON (GB) 2022-05-27 — — WO claimed
CN-106987570-B Cas9 nuclease R780A and application thereof SHANGHAI JIAO TONG UNIVERSITY (CN) 2026-05-26 — — CN disclosed
CN-114080232-B Extracellular vesicles for vaccine delivery Lhasa Sales Co.,Ltd. (CH) 2026-05-26 — — CN disclosed
CN-113853432-B Novel polypeptides for producing patchoulol and/or drimenol compounds 弗门尼舍有限公司 2026-05-15 — — CN disclosed
CN-112752837-B Natural killer cells 帝国理工学院创新有限公司 2026-05-15 — — CN disclosed
CN-116583298-B PD-1 targeted IL-15/IL-15RαFC fusion proteins with improved properties 基因泰克公司 2026-05-12 — — CN disclosed
US-12622975-B2 Peptide-conjugated prodrugs BRANDEIS UNIVERSITY (US) 2026-05-12 — — US disclosed
CN-113121668-B PEG modified polypeptide capable of inhibiting gp96, preparation method and application thereof 北京康明海慧生物科技有限公司 2026-02-27 — — CN disclosed
CN-113980089-A Method for detecting outer membrane vesicles in sample and application of detection kit 富士胶片和光纯药株式会社 2022-01-28 — — CN disclosed
CN-113969286-A Rice cadmium low-accumulation molecular marker, mutant gene, detection kit, rapid identification method and application thereof, and typing primer 湖南杂交水稻研究中心 2022-01-25 — — CN disclosed
CN-113967253-A Immunotherapy by disrupting PD-1/PD-L1 signaling 百时美施贵宝公司 2022-01-25 — — CN disclosed
CN-113960313-A Exosome ALK fusion protein magnetic immunochemiluminescence detection kit 上海思路迪医学检验所有限公司 2022-01-21 — — CN disclosed
CN-113952338-A Methods of treating gefitinib resistant cancers 综合医院公司 2022-01-21 — — CN disclosed
CN-113957087-A Application of Sub gene in regulation and control of cold resistance of rice 天津市农业科学院 2022-01-21 — — CN disclosed
CN-113952459-A Methods of treating gefitinib resistant cancers 综合医院公司 2022-01-21 — — CN disclosed
CN-113957061-A Administration of kynurenine depleting enzymes for tumor therapy 得克萨斯大学体系董事会 2022-01-21 — — CN disclosed
Send feedback